Clinical Trials Directory

Trials / Completed

CompletedNCT05241808

Girls Can...Move! Testing the Feasibility of a Community-based Physical Activity Intervention for Adolescent Girls

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
17 (actual)
Sponsor
Deirdre Dlugonski · Academic / Other
Sex
Female
Age
11 Years – 15 Years
Healthy volunteers
Accepted

Summary

The purpose of this research is to learn about how to promote physical activity among adolescent girls by testing the feasibility and initial effectiveness of the Girls Can...Move! intervention. Girls Can...Move! will target each component of physical literacy by providing opportunities for adolescent girls to gain knowledge about their own physical activity level, to explore and practice different types of physical activities, and to learn from active female role models. Female participants (n = 30) from one middle school will be randomly assigned to the Girls Can...Move! intervention group or a control group at a 1:1 ratio. The primary outcome variables, physical activity and physical literacy, will be assessed before and after the 8-week Girls Can...Move! intervention using accelerometers and online surveys.

Conditions

Interventions

TypeNameDescription
BEHAVIORALGirls Can...Move!Girls Can...Move! is an 8-week intervention designed to increase physical literacy and physical activity among middle school aged girls. One-hour, in-person sessions will be held twice per week for a total of 16 sessions. Each session involves: a brief educational lesson related to physical activity participation, a 30-minute group physical activity session, and a take-home challenge. The physical activities will prioritize enjoyment of physical activity and promote the development of movement competence. These activities may include: yoga; Zumba; Pilates; strength training; kick boxing; circuit training; etc.

Timeline

Start date
2021-12-02
Primary completion
2022-04-26
Completion
2022-04-26
First posted
2022-02-16
Last updated
2022-06-29

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05241808. Inclusion in this directory is not an endorsement.